1Dumonceau JM,Andriulli A,Deviere J,et al.European Society of Gastrointestinal Endoscopy (ESGE) Guideline:prophylaxis of post-ERCP pancreatitis.Endoscopy,2010,42:503-515.
2Cotton PB,Lehman G,Vennes J,et al.Endoscopic sphincterotomy complications and their management:an attempt at consensus.Gastrointest Endoscopy,1991,37:383-393.
4Andriuli A,Imdro G,Niro G,et al.Pharmacologic treatment can prevent pancreatic injury after ERCP:a meta-analysis.Gastrointest Endosc,2000,51:1-7.
5Masci E,Mariani A,Curioni S,et al.Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography:a meta-analysis.Endoscopy,2003,35:830-834.
6Sofuni A,Maguchi H,Itoi T,et al.Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.Clin Gastroenterol Hepatol,2007,5:1339-1346.
7Das A,Singh P,Sivak MV Jr,et al.Pancreatic-stent placement for prevention of post-ERCP pancreatitis:a cost-effectiveness analysis.Gastrointest Endosc,2007,65:960-968.
8Bakmen YG,Safdar K,Freeman ML.Significant clinical implication of prophylactic pancreatic stent placement in previously normal pancreatic ducts.Endoscopy,2009,41:1095-1098.
9Chahal P,Tarnesky PR,Petersen BT,et al.Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis.Clin Gastroenterol Hepatol,2009,7:834-839.
